The retinyl palmitate fat tolerance test was used to measure chylomicron remnant clearance in 10 normal subjects (apolipoprotein E Iapo El isotypes 3 or 4 only), 6 normolipidemic apo E2/2 homozygotes and 5 familial hypercholesterolemic homozygotes. Skin fibroblasts with fully upregulated LDL receptors from the latter subjects degraded rabbit "25I-jBVLDL in vitro at rates ranging from < 10-48% of normal. Experiments in vivo revealed no significant differences between the normal and homozygous familial hypercholesterolemic (FHH) subjects in chylomicron remnant clearance assessed on the basis of "areas under the curves" for retinyl palmitate levels present in postprandial serum, chylomicron remnants (Sf. < 1,000), or chylomicrons (Sf. > 1,000). Remnant clearance was greatly decreased at all times in the apo E2/2 homozygotes, indicative of an important degree of flux control exerted by a receptor-mediated step involving apo E as ligand. The absence of any excess remnant accumulation in FHH subjects with varying "impairment" of LDL receptor-mediated degradation of apo Econtaining lipoproteins, permits the conclusion that chylomicron remnants are initially cleared from the plasma by apo E-recognizing receptors which are genetically distinct from
Introduction
An unresolved question in lipoprotein metabolism is the mechanism(s) by which chylomicron remnants are removed from the circulation (1) . Apolipoprotein E (apo E)' appears to serve as a ligand for receptor-mediated uptake of chylomicron remnants from the plasma (2-6), but the nature of the recep-tor(s) remains uncertain. One possibility is that clearance of chylomicron remnants is mediated at the surfaces of parenchymal liver cells by apolipoprotein B, E (LDL) receptors coded for by a single allelic pair of genes on chromosome 19 (7) . These receptors, which have been detected in liver cells from several species (8) , have a high affinity for apo E and bind chylomicron remnants in vitro (9) . In a recent study, rat chylomicron remnants and apo E-free LDL both bound to hepatic receptor molecules with a molecular weight similar to that of the LDL receptor; and -50% of the chylomicron remnant uptake in perfused rat livers was attributed to receptors that recognized both apo BIOO and apo E (9) . In support of this, Nagata et al. (10) found that an antibody to the LDL receptor markedly decreased the endocytosis of chylomicron remnants by isolated rat hepatocytes.
A cogent reason for questioning the involvement of apo B, E receptors in chylomicron remnant clearance is provided by observations in genetic LDL receptor deficiency. Kita et al. (1 1) found that the removal ofchylomicron remnants from the circulation, and their parallel accumulation in the liver, proceeded at a normal rate in Watanabe heritable hyperlipidemic (WHHL) rabbits, which suffer from homozygous LDL receptor gene mutations associated with a severe LDL receptor deficit. The authors proposed that rabbits express hepatic chylomicron-remnant receptors that are genetically distinct from the LDL receptor (1 1) . Since chylomicron remnants have not been observed in the fasting plasma of patients with homozygous familial hypercholesterolemia (FHH), it has been suggested that humans also express a specific chylomicron-remnant receptor (12) . These observations cannot be considered unequivocal evidence for an LDL receptor-independent pathway for chylomicron remnant clearance, however, as LDL receptor-mediated endocytosis of apo E-containing lipoproteins is catalyzed at significant rates by cultured fibroblasts from some FHH mutants (13) , including WHHL rabbits (14) .
One way of assessing the role of LDL receptors in the clearance of chylomicron remnants from the plasma is to study postprandial chylomicron metabolism in subjects with FHH, especially if the LDL receptor defects are defined with respect to the recognition and metabolism of apo E-containing ligands (1) (19, 20) , postprandial retinyl palmitate concentrations can be used to monitor chylomicron remnant clearance.
Our results indicate that the FHH subjects whose fibroblasts degraded apo E-bearing ,3VLDL at rates ranging from < 10 to -50% of normal, clear chylomicron remnants at the same rate as do normal subjects, while the normolipidemic apo E2/2 homozygotes have grossly delayed clearance of these particles.
Methods

Subjects
Three groups ofsubjects were studied. (a) Five subjects (three men and two women) with FHH were recruited from the lipid clinic at Groote Schuur Hospital (Cape Town). These patients were diagnosed as FH homozygotes on the basis of the following criteria: (i) positive family history of ischemic heart disease. ( (Table II) .
The patients had all been treated with probucol and fortnightly plasma exchange. Three ofthese patients (S.A., R.I., and C.F.) stopped probucol treatment for 3 wk before the study. Fat tolerance studies were performed at least 10 d after plasmapheresis. All Patient A.C. is homozygous for the LDL-receptor mutation most commonly found in Afrikaners (21) that is characterized by slow receptor processing, the expression of a relatively large number of receptors on the cell surface (-60% of normal), and defective LDL binding (-20% of normal) (22) .
Patients C.F., G.V., and S.A. are heteroallelic homozygotes. One of G.V.'s LDL-receptor alleles has the mutation found in A.C. and the other allele has a less common Afrikaner mutation (21 (23) and adopted by others (24). Aliquots (2 ml) of all postprandial samples were underlayered under 9 ml saline (d = 1.006 g/ml) and centrifuged at 8.5 X 109 radians2/s in a Beckman SW40 rotor (Beckman Instruments Inc., Fullerton, CA). Lipoproteins of Sf > 1,000 (1 ml) were aspirated from the surface of the tube. This fraction was designated chylomicrons. Lipoproteins harvested in this manner from normal subjects and from normolipidemic E2/2 subjects produced a single nonmigrating band when subjected to lipoprotein electrophoresis (as described below). This band was not observed in the Sf < 1,000 lipoproteins which were considered to be remnants (data not shown).
To further characterize the plasma distribution ofretinyl palmitate, samples drawn at 0, 2.5, and 7 h from four FHH patients, three E2/2 subjects, and three normal subjects were subjected to discontinuous density gradient ultracentrifugation. 2 (25) . All esters were repurified by preparative HPLC and their purity (> 96%) was determined by spectral analysis on a diode array detector.
Lipid assays. Serum and chylomicron triglyceride concentrations, and serum cholesterol concentrations were determined enzymatically using commercial kits (Boehringer Mannheim, Mannheim, FRG).
The assays were standardized with a lyophilized plasma standard (Precilip; Boehringer Mannheim).
Apolipoprotein E phenotyping. Plasma samples for apo E phenotyping were treated with dithiothreitol (0.01 mmol/ml), after which lipoproteins of density < 1.019 g/ml were isolated by ultracentrifugation in a Beckman SW28 rotor (Beckman Instruments, Inc.). The d < 1.019 lipoprotein factions were delipidated with isopropanol and the supernatants dialyzed against 0.15 M NaCl, 1 mM NaN3, and 1 mM EDTA, pH 7.4 . Apo E phenotypes were determined by two-dimensional electrophoresis using the Iso-Dalt system (26) . The first dimension isoelectric focusing was run in tube gels containing 0.25 g urea, 6.2
Chylomicron Remnant Clearance in Familial Hypercholesterolemia ml H20, 1.8 ml of 30% acrylamide with 1.8% bisacrylamide, 0.5% ampholines of pH 3-10, and 1.5% ampholines of pH 4-6. The second dimension was run on a 15% acrylamide SDS gel and the separated proteins stained with Coomassie blue. Spots corresponding to the apo E isoforms were identified by comparison with known apo E phenotypes.
Degradation of 125I-LDL and 125sI_ VLDL in cultured fibroblasts.
Human LDL (27) and rabbit 3VLDL (28) 
Results
The clinical features of the FHH patients, the normolipidemic E2/2 subjects, and the normal controls are summarized in Table I . All individuals were normotriglyceridemic (fasting triglyceride < 200 mg/dl) and none of the E2/2 or normal subjects were hypercholesterolemic (total cholesterol < 250 mg/dl). Lipoprotein electrophoresis clearly indicated broad beta bands (representing chylomicron and VLDL remnants) in fasting samples from five of the six E2/2 subjects but not in any of the normal or the FHH subjects (data not shown). This observation was supported by ultraviolet absorption profiles of lipoprotein fractions from fasting samples subjected to density gradient centrifugation, which revealed extensive accumulation of IDL particles in E2/2 subjects, but not in the FHH subjects or in the normal controls (data not shown).
The fat meal was well tolerated by all subjects and none developed nausea or diarrhea. At each time point, the mean serum retinyl palmitate concentration was considerably higher in the E2/2 subjects than in the subjects of the other two groups (Fig. 1) . The mean "area under the curve" for PP-SRP in the E2/2 group was markedly higher than in the other groups (P < 0.001) but was similar in normal and in FHH patients (Table I) . During the first half of the test period, the shape of the serum retinyl palmitate curve was similar in normal and in FHH subjects (Fig. 1 ). 7 h after the meal, however, serum retinyl palmitate concentrations were higher in FHH patients than in the normal subjects (see below).
In all groups, most of the retinyl palmitate was present in the remnant fraction (Table I ). The mean "area under the curve" value for PP-RRP in the FHH subjects was not significantly higher than that for the normal subjects (Table I and Fig. 2 ) but was markedly greater in the apo E2/2 subjects. Density gradient ultracentrifugation indicated that normal subjects (measured at 2.5 and 7 h) accumulated RP primarily in the least dense lipoproteins (corresponding to the initially collected fractions in the density range of fasting VLDL), whereas in E2/2 subjects RP was equally distributed throughout the VLDL and the IDL ranges (data not shown). Less than 5% of the serum RP from each of the normal subjects was recovered in the LDL fraction at all time points, while FHH patients showed a progressive accumulation of RP in the LDL fraction. In samples drawn 2.5 h after the meal, RP distribution was similar in FHH and in normal subjects, but 7 h after the meal, an average of 40% of the serum RP in the FHH subjects was carried in the LDL fraction. At this time, neither the normal nor the FHH subjects exhibited the large populations of VLDL-and IDL-sized chylomicron remnants that were evident in the density gradient studies of the E2/2 subjects (data not shown).
Lipoprotein electrophoresis. Fat feeding in the case of both the normal and the FHH subjects did not give rise to broad beta bands such as were present even in the fasting state in the apo E2/2 homozygotes (data not shown).
Serum triglycerides (PP-STG). Serum triglyceride concentrations increased promptly after the meal in each group of subjects (Fig. 3) . The magnitude of postprandial triglyceridemia was not significantly different in any of the groups (Table II).
Degradation of 12sI-LDL and 1251-l VLDL by cultured fibroblasts. The rates of degradation of 125I-LDL and '251-fVLDL by cultured fibroblasts from FHH patients in three separate experiments are shown in Table II . Maximum '25I-fVLDL degradation rates were reduced in all the FHH subjects and showed a wide variation in activity from -50 to < 10% of normal. Maximum '25I-LDL degradation rates followed the same trend as the '25I-OVLDL degradation rates (A.C. > S.A. > G.V. > R.I. and C.F.), ranging from -30 (A.C.) to < 1% of normal (R.I.). There was no correlation between either the PP-RRP (Fig. 4) or PP-SRP values of the individual FHH subjects and the in vitro 3VLDL (or LDL) degradation rates.
Discussion
The clearance of chylomicron remnants from the plasma was not impaired in subjects with FHH. Postprandial retinyl palmitate concentrations in whole serum and in the remnant fraction were similar in normal and in the FHH subjects. Analysis of postprandial lipoproteins, by electrophoresis and by density gradient ultracentrifugation, revealed no abnormal accumulation of IDL-sized lipoproteins in the FHH subjects in the period where triglycerides were being absorbed.
The postprandial concentrations of RP in circulating lipoproteins reflect both absorptive and clearance processes, and it is accordingly possible that impaired chylomicron remnant clearance in the FHH patients was masked by impaired vitamin A absorption. Several lines of evidence argue against this, however. Severe malabsorption of fat was not present as the magnitude of postprandial lipemia was similar in FHH patients and in the other two groups, and none of the subjects had gastrointestinal symptoms of fat malabsorption (such as diarrhea). Alternatively, it might be argued that fat absorption was delayed rather than decreased in the FHH patients. This possibility seems equally unlikely, as the postprandial excursion of serum triglyceride began promptly in the FHH group and returned to baseline values within 7 h. A specific defect in vitamin A absorption secondary to LDL receptor deficiency is also improbable, since serum vitamin A concentrations are normal in FHH patients (30) , and no symptoms of vitamin A deficiency developed in the present group despite fortnightly plasma exchange.
The 7-h time course of our study is sufficient to detect the type of remnant accumulation that would occur if the LDL receptor played a significant role in chylomicron remnant clearance from the plasma. Studies by Havel (31), using radiolabeled apo B48, by Cortner (32), using vitamin A oral fat tolerance tests, and by Berr (19) , using reinjection of vitamin A-labeled chylomicrons, have all shown that the half-life of chylomicron remnants in normal plasma is 15-30 min. If it is assumed that the postprandial rise in plasma triglyceride concentrations represents diet-derived fats (33) , and if plasma retinyl palmitate is born mainly by chylomicron remnants, the postprandial vitamin A excursion should follow the plasma triglyceride curve with a lag of less than 60 min, given normal remnant clearance (this was the case in our normal subjects). Conversely, under conditions where triglyceride clearance is normal but chylomicron remnant clearance is impaired, the vitamin A excursion would show prompt and progressive divergence from the triglyceride curve as remnants accumulated. As dietary fat absorption slowed, input into the remnant pool would cease, and the retinyl ester curve would plateau, reflecting the presence of long-lived remnants in the circulation. This behavior was clearly shown by the apo E2/2 homozygotes in our study, in which remnant particles were detected at 7 h by both electrophoretic analysis and by density gradient ultracentrifugation. In the FHH patients we studied, fat absorption was maximum -1.5 h after the meal, as indicated by plasma triglyceride concentrations. In the critical first 5 h when fat absorption occurred, the retinyl ester responses of the FHH patients were very similar to those of the normal subjects. Impairment of chylomicron remnant clearance would have been apparent at the time when the rate of input of remnants into the circulation was greatest. Thus, Weintraub et al. (34) detected the greatest difference between the chylomicron remnant retinyl palmitate concentrations of normolipidemic E2/3 subjects (who have mildly impaired clearance) and E3/3 subjects at -3 h after the meal.
The main deviation from normal in our FHH subjects was the progressive accumulation of retinyl palmitate in the LDL flotation range, which accounted for 40% oftheir serum retinyl palmitate at 7 h. This accounted for more than 70% of the discrepancy between RP levels (in serum or in the remnant fraction) of the FHH and normal subjects at this time point. The increased LDL-RP during vitamin A fat tolerance tests, which has been reported previously (19, 20) , is believed to This study has measured the clearance from the plasma, but not the uptake into the liver ofchylomicron remnants. The conclusion that LDL receptors do not play a significant role in chylomicron remnant clearance from the plasma, does not preclude the suggestion that low numbers of LDL receptors may be sufficient to endocytose remnant particles, which have been "precleared" from the circulation by high capacity binding sites in hepatic sinusoids, possibly of a glycosaminoglycan nature (1) .
In summary, the results of this study indicate that chylomicron remnant clearance shows normal kinetic features in a set of FHH subjects with varying degrees of LDL receptor deficiency, but is greatly impaired in normolipidemic apo E2/2 homozygotes. Interpretation of these findings in the light of metabolic control analysis suggests that chylomicron remnants are initially removed from the circulation mainly by receptors that recognize apo E but are genetically distinct from LDL receptors.
